UBS O'Connor’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-325,314
| Closed | -$836K | – | 558 |
|
|
2024
Q2 | $836K | Buy |
325,314
+70,647
| +28% | +$182K | 0.02% | 312 |
|
|
2024
Q1 | $1.25M | Buy |
254,667
+145,000
| +132% | +$713K | 0.04% | 249 |
|
|
2023
Q4 | $964K | Buy |
109,667
+20,867
| +23% | +$183K | 0.03% | 270 |
|
|
2023
Q3 | $1.02M | Buy |
+88,800
| New | +$1.02M | 0.02% | 321 |
|
|
2023
Q2 | – | Sell |
-20,214
| Closed | -$651K | – | 617 |
|
|
2023
Q1 | $651K | Buy |
+20,214
| New | +$651K | 0.02% | 436 |
|
|
2022
Q4 | – | Sell |
-101,179
| Closed | -$2.73M | – | 378 |
|
|
2022
Q3 | $2.73M | Sell |
101,179
-74,000
| -42% | -$2M | 0.03% | 464 |
|
|
2022
Q2 | $2.42M | Buy |
+175,179
| New | +$2.42M | 0.03% | 609 |
|